Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families

Jeffrey N. Weitzel, Veronica I. Lagos, Josef S. Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S. Ho, Charité N. Ricker, Katrina J. Lowstuter, Kathleen R. Blazer, Gail Tomlinson and Tom Scholl
Jeffrey N. Weitzel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronica I. Lagos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef S. Herzog
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thaddeus Judkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brant Hendrickson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason S. Ho
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charité N. Ricker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrina J. Lowstuter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen R. Blazer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Tomlinson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Scholl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-07-0198 Published August 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Gene copy number analysis by multiplexed quantitative differential PCR for BRCA1 and BRCA2 for 23 DNA specimens obtained from patients of Hispanic ancestry. Three samples (1659, 1744, 2025) revealed a deletion of exons 9 to 12 in BRCA1 (boxed in the graph, arrows in the graph legend). A dosage ratio of 0.8 to 1.25 indicates normal copy number (two alleles); a value above 1.3 indicates gain of one allele; and a value less than 0.7 indicates a loss of one allele. Each gene has been arranged 5′ to 3′. Control DNAs are encircled (BRCA1 duplication exon 13; BRCA1 deletion exons 14-20). The elevated ratios of the BRCA2 exons for the del 14-20 control and positive patient samples is a normalization echo created by using the two genes as dosage controls for each other in the multiplexes.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Diagram of the 3-primer BRCA1 del (ex 9-12) assay. A, genomic structure of breakpoint region with numbered exons. Solid blocks, BRCA1 exons 8 to 13; close crosshatch bar, intron 8; distinct crosshatch patterns, introns involved in rearrangement; open bars, introns 9 to 11. Bracket below the diagram, positions of the respective breakpoints. Primer positions for the specific rearrangement assay (P1, P2, P3) are indicated along with respective orientation. Although not detectable in assay, predicted product for P1 and P3 (15.4 kb) wild-type allele is indicated by parentheses above diagram. B, depiction of the wild-type (P1 and P2) and rearrangement mutation-specific (P1 and P3) PCR products. C, photograph of ethidium bromide–stained agarose gel with cases (first five lanes) and controls (wt, water). Size standard indicated on right. Clean bands of 1,145 and 742 bp represent the wild-type and mutant alleles in positive cases (lanes 1-5), while the wild-type control (lane 6) shows only the wild-type allele.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    BRCA1 deletion exon 9 to 12 breakpoint localized within AluSp sequence in intron 8 and AluSx sequence in intron 12. The sequence of the 2.7-kb product spanning the breakpoint was determined and mapped against BRCA1 genomic sequence [National Center forBiotechnology Information (NCBI) accession no. L78833] by RepeatMasker v3.1.X software (A.F.A. Smit, R. Hubley and P. Green RepeatMasker at http://repeatmasker.org). The breakpoint is depicted as a consensus block of identity; thus, the precise point of recombination and which respective Alu element contributed to that cannot be determined. The intronic breakpoint region is depicted, with unique intron 8 sequence leading to the specific AluSp (single underline) element, adjacent to the consensus block (boxed), and the 3′ AluSx element (double underline) in intron 12 sequence.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    BRCA1 protein functional domains and predicted frameshift and premature truncation. A, adapted from Welcsh et al., 2000 (42): Translated BRCA1 exons and distribution of known/putative functional domains for BRCA1 protein. B, depiction of truncated coding sequence resulting from deletion of exons 9 to 12. C, predicted frameshift and premature stop codon that would result from direct splicing of the remaining exons (8 joined to 13), presuming no use of cryptic or alternate splice sites.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    BRCA1 del (ex 9-12) haplotype. The haplotype was determined from the mother (2025-14) and daughter (2025-1) pair (in bold type). No determination was made for marker D17S1327 as the genotype is equivalent in both mother and daughter. Dash, deleted marker D17S1323 in the mutant allele. For the other four cases, a genotype was established. All the individuals carrying the mutation carried the alleles associated with the haplotype, suggesting that this is a founder mutation.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Pedigrees for four families with the BRCA1 del (ex 9-12) mutation. Squares, males; circles, females. Age at cancer risk assessment or death is provided below each individual; deceased individuals are indicated by a hatch mark and age at death. The arrow by the filled circle indicates the tested individual; age at breast cancer (BC) or ovarian cancer (OC) onset is shown.

Tables

  • Figures
  • Table 1.

    Demographics and clinical characteristics (N = 106)

    VariableBRCA1 del (ex 9-12) mutation status
    CarrierNoncarrier
    n (%)4 (3.8%)102 (96.2%)
    Gender
        Male01 (0.1%)
        Female4 (100%)101 (99.0%)
    Cancer status
        Unaffected (%)05 (4.9%)
        Affected with BC and/or OC (%)4 (100%)97 (95.1%)
            BC (%)3 (75.0%)77 (79.4%)
            Bilateral BC1 (25.0%)10 (10.3%)
            OC (%)04 (4.1%)
            BC and OC (%)03 (3.1%)
            DCIS (%)03 (3.1%)
    Average age at first BC diagnosis ± SD37.0 ± 3.637.9 ± 8.0
    Probands' parental country(ies) of origin*
        No. Mexican (%)3 (75.0%)66 (64.7%)
        No. Central American/Caribbean (%)014 (13.7%)
        No. South American (%)03 (2.9%)
        No. Spanish (%)02 (2.0%)
        No. mixed† (%)1 (25.0%)17 (16.7%)
    • Abbreviations: BC, breast cancer; OC, ovarian cancer; DCIS, ductal carcinoma in situ.

    • ↵* Applies to both parental lineages; except those with mixed ancestry indicated in the last category.

    • ↵† “Mixed” means a combination of above or combination of Hispanic and non-Hispanic ancestry.

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 16 (8)
August 2007
Volume 16, Issue 8
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families
Jeffrey N. Weitzel, Veronica I. Lagos, Josef S. Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S. Ho, Charité N. Ricker, Katrina J. Lowstuter, Kathleen R. Blazer, Gail Tomlinson and Tom Scholl
Cancer Epidemiol Biomarkers Prev August 1 2007 (16) (8) 1615-1620; DOI: 10.1158/1055-9965.EPI-07-0198

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families
Jeffrey N. Weitzel, Veronica I. Lagos, Josef S. Herzog, Thaddeus Judkins, Brant Hendrickson, Jason S. Ho, Charité N. Ricker, Katrina J. Lowstuter, Kathleen R. Blazer, Gail Tomlinson and Tom Scholl
Cancer Epidemiol Biomarkers Prev August 1 2007 (16) (8) 1615-1620; DOI: 10.1158/1055-9965.EPI-07-0198
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Urinary Melatonin in Relation to Breast Cancer Risk
  • Endometrial Cancer and Ovarian Cancer Cross-Cancer GWAS
  • Risk Factors of Subsequent CNS Tumor after Pediatric Cancer
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement